Overview
Shapely positions itself around insurance coverage first — its own site headline references insurance-covered Ozempic, Wegovy and GLP-1 weight loss — while maintaining a genuinely low-cost compounded self-pay tier underneath it.
That compounded pricing sits at the market floor: compounded semaglutide starting at $99 per month and compounded tirzepatide starting at $166 per month, offered on a self-pay basis when prescribed. Shapely repeats these figures consistently across its site, including on its medication and Medicare pages.
On sourcing, Shapely states it works with reputable state-licensed 503A and 503B compounding pharmacies and ships medication directly to your door with no need for insurance. Naming both tiers is more disclosure than most competitors offer, though Shapely does not identify the specific facilities.
Shapely is also careful about a distinction many platforms blur: it states plainly that it is not affiliated with Novo Nordisk, Eli Lilly, or their patient programs. That matters, because a patient pursuing manufacturer savings programs needs to understand that a telehealth platform’s insurance assistance is a separate thing from the manufacturer’s own offer.
What Makes Shapely Different
Insurance-First Positioning With a Real Cash Fallback
Most platforms are one or the other. Shapely leads with pursuing coverage for brand-name Ozempic and Wegovy, but keeps compounded semaglutide at $99 and tirzepatide at $166 available on a self-pay basis when coverage is not achievable.
Discloses Both 503A and 503B Pharmacy Use
Shapely states it works with reputable state-licensed 503A and 503B compounding pharmacies. Acknowledging both tiers is more than most competitors disclose, though the specific facilities are not named — worth asking about directly.
Compounded Tirzepatide at $166
The dual GIP/GLP-1 molecule is typically the expensive one, priced at $199 to $399 across most of this market. At $166 Shapely undercuts the large majority of compounded tirzepatide pricing.
Explicit About Not Being Manufacturer-Affiliated
Shapely states it is not affiliated with Novo Nordisk, Eli Lilly or their patient programs. That is a useful clarification for patients who might otherwise assume a platform’s insurance help is the same as a manufacturer savings program.
✓ Pros
- •Compounded semaglutide from $99/month – at the market floor
- •Compounded tirzepatide from $166/month – well below most competitors
- •Insurance pathway for brand-name – Ozempic and Wegovy coverage pursued
- •Discloses 503A and 503B pharmacy use – more than most competitors state
- •Direct-to-door shipping – no insurance needed for the compounded route
- •Medicare-specific guidance published – a population most platforms ignore
- •Clear about manufacturer non-affiliation – avoids a common misunderstanding
- •Consistent pricing across its site – the same figures repeat rather than varying by page
✗ Cons
- •Specific pharmacies not named – tiers disclosed but facilities are not
- •Compounded regulatory position has narrowed – since GLP-1s left the FDA shortage list
- •Advertised prices are starting figures – confirm cost at maintenance dose
- •Insurance outcomes depend entirely on your plan – coverage is not guaranteed
- •Limited independent review coverage – less third-party scrutiny than larger platforms
- •No bundled dietitian or coaching – medication and clinical access only
- •Cancellation and refund terms not prominently published – confirm in writing
Our #1 Recommended Provider
Shapely’s compounded pricing is genuinely competitive and its insurance pathway is useful. If you want disclosed pharmacy sourcing at a comparable price, Coreage RX remains our top recommendation.
Medications Offered
Brand-Name or Compounded?
Both. Shapely pursues insurance coverage for brand-name FDA-approved GLP-1s including Ozempic and Wegovy, and offers compounded semaglutide and tirzepatide on a self-pay basis when prescribed. Shapely states it works with reputable state-licensed 503A and 503B compounding pharmacies, and that it is not affiliated with Novo Nordisk, Eli Lilly or their patient programs.
Compounded semaglutide
Starting at $99/month self-payOnce-weekly injectable prescribed to support appetite control and weight management. Shipped directly to your door with no insurance needed. Compounded products are not FDA-approved.
Compounded tirzepatide
Starting at $166/month self-payThe dual GIP/GLP-1 molecule. At $166 this undercuts most compounded tirzepatide pricing in the market, where $199 to $399 is typical.
Brand-name Ozempic and Wegovy
Your insurance cost where coverage is achievedShapely’s headline positioning is insurance-covered brand-name access. Coverage depends entirely on your plan’s formulary and prior authorization outcome.
Medicare pathway
Depends on your Medicare coverageShapely publishes Medicare-specific guidance covering Ozempic, Mounjaro and other products. Medicare coverage for obesity medication has historically been very limited — verify what applies to your specific plan.
Advertised figures are starting prices for self-pay compounded medication. Confirm the cost at your expected maintenance dose before enrolling, and treat the insurance pathway as a possibility rather than a guarantee — coverage depends on your formulary, not on the platform’s efforts.
Pricing, Membership & Medication Fees
| Cost Item | What You Pay |
|---|---|
| Compounded semaglutide | Starting at $99/month self-pay |
| Compounded tirzepatide | Starting at $166/month self-pay |
| Brand-name via insurance | Your plan’s cost share where coverage is achieved |
| Pharmacy tiers | State-licensed 503A and 503B compounding pharmacies per Shapely |
| Shipping | Direct to your door; no insurance needed for the compounded route |
| Manufacturer affiliation | Shapely states it is not affiliated with Novo Nordisk, Eli Lilly or their patient programs |
| Medicare | Shapely publishes Medicare-specific guidance; coverage depends on your plan |
Shapely’s compounded pricing is among the most competitive in the market, particularly on tirzepatide at $166 where most competitors charge $199 to $399. Treat the insurance pathway as upside rather than the plan — most commercial formularies still exclude obesity medication, and the compounded rate is what you should budget against.
How Shapely Works
Complete the Intake and Insurance Check
Shapely leads with pursuing insurance coverage for brand-name GLP-1s. Provide your insurance details so the platform can establish whether coverage is achievable before you default to the self-pay route.
Provider Review and Prescription
A medical provider reviews your information and determines whether a GLP-1 is clinically appropriate and which product fits. Both brand-name and compounded routes are available depending on the coverage outcome.
Choose Insurance or Compounded Self-Pay
If coverage is achieved, you pay your plan’s cost share for brand-name product. If not, compounded semaglutide starts at $99 per month and tirzepatide at $166, offered on a self-pay basis.
Ask Which Pharmacy Is Dispensing
Shapely states it works with state-licensed 503A and 503B compounding pharmacies but does not name them publicly. Ask which specific facility is preparing your prescription and under which tier — 503B facilities operate under FDA current good manufacturing practice requirements.
Direct-to-Door Delivery
Shapely ships medication straight to your door. Injectable GLP-1s are temperature-sensitive and should go into refrigeration promptly on arrival.
Ongoing Titration and Support
Your provider manages dose escalation. Contact them promptly if gastrointestinal symptoms are severe rather than pushing through them, and confirm what ongoing support is included in your plan.
Program Details at a Glance
| Detail | Shapely |
|---|---|
| Consultation process | Online intake with medical provider review, including an insurance check for brand-name coverage where applicable. |
| Eligibility | Adults meeting clinical criteria for GLP-1 therapy, as determined by the reviewing provider. |
| Provider involvement | Medical providers review, prescribe and manage the treatment pathway across both insurance and self-pay routes. |
| Lab requirements | Confirm lab requirements directly with Shapely for your situation. |
| Pharmacy fulfillment | Shapely states it works with reputable state-licensed 503A and 503B compounding pharmacies. Specific facilities are not named publicly — ask directly which is preparing your prescription. |
| Shipping frequency | Medication shipped straight to your door, with no insurance needed for the compounded route. Injectables require refrigeration on arrival. |
| Support services | Provider-managed treatment. Confirm what ongoing support and messaging access is included in your specific plan. |
| Membership fee | Not prominently published as a separate charge. Confirm whether any membership or program fee applies on top of the quoted medication price. |
| Medication fee | Compounded semaglutide from $99/month and compounded tirzepatide from $166/month on a self-pay basis. Brand-name cost depends on your insurance coverage. |
| Cancellation policy | Cancellation terms are not prominently published. Confirm directly with Shapely in writing before enrolling. |
| Refund policy | Refund terms are not prominently published. Confirm directly with Shapely before committing to any prepaid period. |
| Insurance | Central to Shapely’s positioning. The platform pursues coverage for brand-name Ozempic and Wegovy. Compounded medication is a cash-pay pathway. Shapely states it is not affiliated with Novo Nordisk, Eli Lilly or their patient programs. |
| HSA / FSA | Prescription and eligible medical costs are generally HSA/FSA eligible. Confirm with your plan administrator. |
| States served | Availability depends on provider licensure in your state. Confirm before enrolling. |
Who Shapely Is Best For
✓ Best For:
- • Patients who want both insurance and self-pay routes explored
- • Cost-conscious patients drawn to $99 compounded semaglutide
- • Anyone wanting compounded tirzepatide affordably, at $166/month
- • Patients who value knowing both 503A and 503B tiers are used
- • Medicare beneficiaries seeking guidance on their options
- • People who want brand-name coverage pursued before defaulting to cash-pay
✗ Not Best For:
- • Patients who require named, verifiable pharmacy sourcing upfront
- • Anyone wanting bundled dietitian or coaching support
- • People who need published cancellation and refund terms before enrolling
- • Patients who want extensive independent third-party review coverage
- • Anyone uncomfortable with compounded medication’s current regulatory position
- • People who want a guaranteed insurance outcome
Limitations to Know Before You Sign Up
- ⚠️Shapely discloses that it uses 503A and 503B compounding pharmacies but does not name the specific facilities. Ask which is preparing your prescription — the oversight differs meaningfully between the two tiers.
- ⚠️Advertised prices are starting figures. Confirm the cost at your expected maintenance dose before enrolling.
- ⚠️The insurance pathway is a pursuit, not a guarantee. Most commercial formularies still exclude obesity medication, so budget against the compounded self-pay rate.
- ⚠️Cancellation and refund terms are not prominently published. Get them in writing before committing to any prepaid period.
- ⚠️There is limited independent third-party review coverage of Shapely relative to larger platforms, so less external scrutiny is available.
- ⚠️Compounded semaglutide and tirzepatide are not FDA-approved products, and the regulatory position narrowed after both molecules left the FDA shortage list.
Alternatives to Shapely
Coreage RX
Our top-rated provider at a flat $99/month with 503B sourcing disclosed and both molecules at one price.
Trimi
Compounded tirzepatide at $125/month on annual plans, with named pharmacies and published licence numbers.
Zealthy
Another dual-track platform running both compounded and insurance-covered brand-name routes.
Ro
A larger platform with a dedicated insurance concierge for pursuing brand-name coverage.
Frequently Asked Questions
How much does Shapely cost?
When prescribed, compounded medications are offered on a self-pay basis starting at $99 per month for compounded semaglutide and $166 per month for compounded tirzepatide. Brand-name medication cost depends on whether insurance coverage is achieved and what your plan’s cost share is.
Does Shapely take insurance?
Shapely’s headline positioning is insurance-covered Ozempic, Wegovy and GLP-1 weight loss, so the platform pursues coverage for brand-name products. Compounded medication is a self-pay pathway. Coverage outcomes depend on your formulary.
Which pharmacies does Shapely use?
Shapely states it works with reputable state-licensed 503A and 503B compounding pharmacies. It does not name the specific facilities publicly, so ask directly which one is preparing your prescription and under which tier.
Is Shapely affiliated with Novo Nordisk or Eli Lilly?
No, and Shapely states this explicitly. That is a useful clarification, because a telehealth platform’s insurance assistance is a separate thing from a manufacturer’s own patient savings program.
Is $166 a good price for compounded tirzepatide?
Yes — it undercuts the large majority of this market, where compounded tirzepatide typically runs $199 to $399 per month. Only a handful of providers, such as Trimi at $125 and Fifty 410 at $133, are cheaper.
Does Shapely work for Medicare patients?
Shapely publishes Medicare-specific guidance covering Ozempic, Mounjaro and other products. Medicare coverage for obesity medication has historically been very limited, so verify what applies to your specific plan rather than assuming.
Is compounded semaglutide the same as Wegovy?
No. It contains the same active ingredient but is not an FDA-approved product and is prepared by a compounding pharmacy rather than the manufacturer. The regulatory basis for routine compounding narrowed after semaglutide left the FDA shortage list.
Can I cancel anytime?
Shapely does not prominently publish cancellation and refund terms. Get them in writing before enrolling, particularly if you are considering any multi-month arrangement.
The Bottom Line
Shapely earns 4.0 out of 5 stars for running both tracks competently and pricing the cash-pay tier aggressively. Compounded semaglutide at $99 per month sits at the market floor, and compounded tirzepatide at $166 undercuts the large majority of competitors on the molecule that is usually the expensive one.
The insurance-first positioning is sensible rather than cosmetic. Leading with an attempt at brand-name coverage and keeping a genuinely cheap compounded fallback underneath means patients are not forced to choose their lane before finding out which is achievable. Publishing Medicare-specific guidance also addresses a population most of this market ignores entirely.
We credit Shapely for two disclosures. Acknowledging that it works with both 503A and 503B pharmacies is more than most competitors state, and saying plainly that it is not affiliated with Novo Nordisk, Eli Lilly or their patient programs prevents a genuine and common misunderstanding.
What holds it back is verification. The pharmacy tiers are disclosed but the facilities are not named, cancellation and refund terms are not prominently published, and there is limited independent third-party coverage to check the company’s claims against. Our recommendation: Shapely is a strong-value option worth shortlisting, especially for tirzepatide. Before enrolling, ask which pharmacy is dispensing and get the cancellation terms in writing. If you want comparable pricing with sourcing disclosed upfront, Coreage RX and Trimi are the closest comparisons.
Disclosure:
This review is based on publicly available information from Shapely’s own website, medication pages and Medicare guidance pages, current as of August 25, 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews; we do not have a compensation relationship with Shapely. Advertised prices are starting figures for self-pay compounded medication and are subject to change; confirm the cost at your expected maintenance dose. Insurance coverage outcomes depend entirely on individual plan formularies and are not guaranteed by any platform. Shapely does not name its specific compounding pharmacies publicly — patients should request this information directly. Compounded medications are not FDA-approved and their regulatory position narrowed after semaglutide and tirzepatide left the FDA shortage list. We do not sell, dispense, or ship medication.
⚕️ Medical Disclaimer:
This review is for informational purposes only and is not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or other concerning symptoms, seek medical care immediately. See our full medical disclaimer.
Or check out our top-rated provider